| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.083 | 0.6 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |